-
Dysport and Relfydess are prescription only medications that contain the active ingredient, botulinum toxin type A. They relax targeted facial muscles to soften the appearance of fine lines and wrinkles.
They work to temporarily block the nerve signals that cause the muscle to contract, allowing the skin to appear smoother.
-
Yes, Dysport is a well established injectable that has been used worldwide since the early 1990s.
Relfydess is a recently launched neuromodulator, with clinical trials and regulatory reviews showing it is well tolerated.
When administered by a qualified and trained professional, neuromodulators are considered safe and effective.
-
The number of units required varies from person to person and depends on the treatment area, muscle strength, facial anatomy and desired result.
Dysport and Relfydess:
Typical unit ranges (as a guide only):
Frown lines - 40 - 60 units
Forehead lines - 20 - 60 units
Crows feet - 20 - 40 units per side
Cost per unit of Dysport is $5.50. Cost per unit of Relfydess is $6.50
-
DYSPORT
You may notice results within 2-3 days after treatment. Full results are usually visible 14 days after treatment.
RELFYDESS
You may notice results within 24 hours of treatment. Full results are usually visible 3 weeks after treatment.
-
DYSPORT
Results usually last 3-4 months, depending on your metabolism, lifestyle and treatment area.
RELFYDESS
Recent clinical trials show up to 75% of clientβs studied did not return to baseline after 6 months of treatment. In other words, Relfydess can last 6 months and beyond depending on your metabolism, lifestyle and treatment area.
-
Most clients report minimal discomfort. The needle is very fine and the treatment is quick.
-
Dysport and Relfydess are not suitable if you are pregnant or breastfeeding, have certain neuromuscular conditions, an allergy to botulinum toxin or have an active infection at the treatment site.
A full consultation is always required to ensure suitability.
-
Side effects are usually mild and temporary and may include redness, swelling or bruising at the injection site.